Table 1 Patient demographics and clinical characteristics
Group | Severe (n = 74) | Mild (n = 25) |
|---|---|---|
Age - mean (range) | 54 (29–80) | 47 (25–92) |
Male sex - n° (%) | 55 (74.3%) | 11 (44%) |
COVID-19 vaccination - n° (%) | 0 (0%) | 0 (0%) |
Diagnosis test | ||
PCR | 60 (81.1%) | 21 (84%) |
Antigen test | 14 (18.9%) | 3 (12%) |
Serology | 0 | 1(4%) |
Sample collection POS - days (%) | ||
0–14 | 33 (44.6%) | 17 (68%) |
15–31 | 41 (55.4%) | 7 (28%) |
Risk factors for severe Covid-19 - n° (%) | 47 (64%) | 14 (56%) |
Individuals with more than 1 risk factor | 26 (35.1%) | 7 (28%) |
Obesity | 22 (29.7%) | 4 (16%) |
Diabetes | 18 (24.3%) | 3 (12%) |
Hypertension | 22 (29.7%) | 6 (24%) |
Rheumatoid arthritis | 1 (1.4%) | 1 (4%) |
Chronic liver disease | 6 (8.1%) | 3 (12%) |
Chronic kidney disease | 4 (5.4%) | 2 (8%) |
Heart disease | 1 (1.4%) | 4 (16%) |
Pneumopathy | 9 (12.2%) | 4 (16%) |
Pregnancy | 0 (0%) | 6 (24%) |
Smoking | 2 (2.7%) | 0 (0%) |
Antiviral therapies/treatment | ||
>1 treatment/patient | 51 (69%) | 3 (12%) |
Corticosteroids | 48 (64.9%) | 7 (28%) |
Antivirala | 49 (66.2%) | 6 (24%) |
Antibodiesb | 28 (37.8%) | 1 (4%) |
Other | 4 (5.4%) | 1 (4%) |
